-
Je něco špatně v tomto záznamu ?
Cervical lymph node metastasis in adenoid cystic carcinoma of oral cavity and oropharynx: A collective international review
C. Suárez, L. Barnes, CE. Silver, JP. Rodrigo, JP. Shah, A. Triantafyllou, A. Rinaldo, A. Cardesa, KT. Pitman, LP. Kowalski, KT. Robbins, H. Hellquist, JE. Medina, R. de Bree, RP. Takes, A. Coca-Pelaz, PJ. Bradley, DR. Gnepp, A. Teymoortash, P....
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, přehledy
- MeSH
- adenoidně cystický karcinom patologie terapie MeSH
- krční disekce * MeSH
- krk MeSH
- lidé MeSH
- lokální recidiva nádoru * MeSH
- lymfatické metastázy MeSH
- lymfatické uzliny patologie MeSH
- management nemoci MeSH
- nádory orofaryngu patologie terapie MeSH
- nádory úst patologie terapie MeSH
- radioterapie * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The purpose of this study was to suggest general guidelines in the management of the N0 neck of oral cavity and oropharyngeal adenoid cystic carcinoma (AdCC) in order to improve the survival of these patients and/or reduce the risk of neck recurrences. The incidence of cervical node metastasis at diagnosis of head and neck AdCC is variable, and ranges between 3% and 16%. Metastasis to the cervical lymph nodes of intraoral and oropharyngeal AdCC varies from 2% to 43%, with the lower rates pertaining to palatal AdCC and the higher rates to base of the tongue. Neck node recurrence may happen after treatment in 0-14% of AdCC, is highly dependent on the extent of the treatment and is very rare in patients who have been treated with therapeutic or elective neck dissections, or elective neck irradiation. Lymph node involvement with or without extracapsular extension in AdCC has been shown in most reports to be independently associated with decreased overall and cause-specific survival, probably because lymph node involvement is a risk factor for subsequent distant metastasis. The overall rate of occult neck metastasis in patients with head and neck AdCC ranges from 15% to 44%, but occult neck metastasis from oral cavity and/or oropharynx seems to occur more frequently than from other locations, such as the sinonasal tract and major salivary glands. Nevertheless, the benefit of elective neck dissection (END) in AdCC is not comparable to that of squamous cell carcinoma, because the main cause of failure is not related to neck or local recurrence, but rather, to distant failure. Therefore, END should be considered in patients with a cN0 neck with AdCC in some high risk oral and oropharyngeal locations when postoperative RT is not planned, or the rare AdCC-high grade transformation.
Consultant Pathologist Southern California Permanente Medical Group Woodland Hills CA USA
Coordinator of the International Head and Neck Scientific Group
Department of Anatomic Pathology Hospital Clinic University of Barcelona Barcelona Spain
Department of Biomedical Sciences and Medicine University of Algarve Faro Portugal
Department of Otolaryngology Head and Neck Surgery Philipp University Marburg Germany
Department of Otolaryngology Hospital Universitario Central de Asturias Oviedo Spain
Department of Pathology Allegiance Health Jackson MI USA
Department of Pathology Beth Israel Medical Center New York NY USA
Department of Pathology Charles University Prague Faculty of Medicine in Plzen Plzen Czech Republic
Department of Pathology Radboud University Medical Center Nijmegen The Netherlands
Department of Pathology The University of Texas MD Anderson Cancer Center Houston TX USA
Department of Pathology University of Pittsburgh School of Medicine Pittsburgh PA USA
Department of Radiation Oncology Institute of Oncology Ljubljana Slovenia
Department of Radiation Oncology University of Florida Gainesville FL USA
Department of Surgery Banner MD Anderson Cancer Center Gilbert AZ USA
European Salivary Gland Society Geneva Switzerland
Fundación de Investigación e Innovación Biosanitaria del Principado de Asturias Oviedo Spain
Head and Neck Surgery Memorial Sloan Kettering Cancer Center New York NY USA
Instituto Universitario de Oncología del Principado de Asturias Universidad de Oviedo Oviedo Spain
University of Udine School of Medicine Udine Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013991
- 003
- CZ-PrNML
- 005
- 20170427120334.0
- 007
- ta
- 008
- 170413s2016 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.anl.2016.02.013 $2 doi
- 035 __
- $a (PubMed)27017314
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Suárez, Carlos $u Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, Oviedo, Spain; Fundación de Investigación e Innovación Biosanitaria del Principado de Asturias, Oviedo, Spain.
- 245 10
- $a Cervical lymph node metastasis in adenoid cystic carcinoma of oral cavity and oropharynx: A collective international review / $c C. Suárez, L. Barnes, CE. Silver, JP. Rodrigo, JP. Shah, A. Triantafyllou, A. Rinaldo, A. Cardesa, KT. Pitman, LP. Kowalski, KT. Robbins, H. Hellquist, JE. Medina, R. de Bree, RP. Takes, A. Coca-Pelaz, PJ. Bradley, DR. Gnepp, A. Teymoortash, P. Strojan, WM. Mendenhall, JA. Eloy, JA. Bishop, KO. Devaney, LD. Thompson, M. Hamoir, PJ. Slootweg, V. Vander Poorten, MD. Williams, BM. Wenig, A. Skálová, A. Ferlito,
- 520 9_
- $a The purpose of this study was to suggest general guidelines in the management of the N0 neck of oral cavity and oropharyngeal adenoid cystic carcinoma (AdCC) in order to improve the survival of these patients and/or reduce the risk of neck recurrences. The incidence of cervical node metastasis at diagnosis of head and neck AdCC is variable, and ranges between 3% and 16%. Metastasis to the cervical lymph nodes of intraoral and oropharyngeal AdCC varies from 2% to 43%, with the lower rates pertaining to palatal AdCC and the higher rates to base of the tongue. Neck node recurrence may happen after treatment in 0-14% of AdCC, is highly dependent on the extent of the treatment and is very rare in patients who have been treated with therapeutic or elective neck dissections, or elective neck irradiation. Lymph node involvement with or without extracapsular extension in AdCC has been shown in most reports to be independently associated with decreased overall and cause-specific survival, probably because lymph node involvement is a risk factor for subsequent distant metastasis. The overall rate of occult neck metastasis in patients with head and neck AdCC ranges from 15% to 44%, but occult neck metastasis from oral cavity and/or oropharynx seems to occur more frequently than from other locations, such as the sinonasal tract and major salivary glands. Nevertheless, the benefit of elective neck dissection (END) in AdCC is not comparable to that of squamous cell carcinoma, because the main cause of failure is not related to neck or local recurrence, but rather, to distant failure. Therefore, END should be considered in patients with a cN0 neck with AdCC in some high risk oral and oropharyngeal locations when postoperative RT is not planned, or the rare AdCC-high grade transformation.
- 650 _2
- $a adenoidně cystický karcinom $x patologie $x terapie $7 D003528
- 650 _2
- $a management nemoci $7 D019468
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lymfatické uzliny $x patologie $7 D008198
- 650 _2
- $a lymfatické metastázy $7 D008207
- 650 _2
- $a nádory úst $x patologie $x terapie $7 D009062
- 650 _2
- $a krk $7 D009333
- 650 12
- $a krční disekce $7 D037981
- 650 12
- $a lokální recidiva nádoru $7 D009364
- 650 _2
- $a nádory orofaryngu $x patologie $x terapie $7 D009959
- 650 12
- $a radioterapie $7 D011878
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Barnes, Leon $u Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
- 700 1_
- $a Silver, Carl E $u Departments of Surgery and Otolaryngology - Head and Neck Surgery, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA.
- 700 1_
- $a Rodrigo, Juan P $u Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, Oviedo, Spain; Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain.
- 700 1_
- $a Shah, Jatin P $u Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- 700 1_
- $a Triantafyllou, Asterios $u Oral and Maxillofacial Pathology, School of Dentistry, University of Liverpool and Cellular Pathology, Liverpool Clinical Laboratories, Liverpool, UK.
- 700 1_
- $a Rinaldo, Alessandra $u University of Udine School of Medicine, Udine, Italy.
- 700 1_
- $a Cardesa, Antonio $u Department of Anatomic Pathology, Hospital Clinic, University of Barcelona, Barcelona, Spain.
- 700 1_
- $a Pitman, Karen T $u Department of Surgery, Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
- 700 1_
- $a Kowalski, Luiz P $u Department of Head and Neck Surgery and Otorhinolaryngology, A.C. Camargo Cancer Center, São Paulo, Brazil.
- 700 1_
- $a Robbins, K Thomas $u Division of Otolaryngology-Head and Neck Surgery, Southern Illinois University School of Medicine, Springfield, IL, USA.
- 700 1_
- $a Hellquist, Henrik $u Department of Biomedical Sciences and Medicine, University of Algarve, Faro, Portugal.
- 700 1_
- $a Medina, Jesus E $u Department of Otorhinolaryngology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
- 700 1_
- $a de Bree, Remco $u Department of Head and Neck Surgical Oncology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
- 700 1_
- $a Takes, Robert P $u Department of Otolaryngology-Head and Neck Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
- 700 1_
- $a Coca-Pelaz, Andrés $u Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain.
- 700 1_
- $a Bradley, Patrick J $u Department of Otolaryngology - Head and Neck Surgery, Nottingham University Hospitals, Queens Medical Centre Campus, Nottingham, UK; European Salivary Gland Society, Geneva, Switzerland.
- 700 1_
- $a Gnepp, Douglas R $u University Pathologists, Providence, RI, USA; University Pathologists, Fall River, MA, USA.
- 700 1_
- $a Teymoortash, Afshin $u Department of Otolaryngology-Head and Neck Surgery, Philipp University, Marburg, Germany.
- 700 1_
- $a Strojan, Primož $u Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia.
- 700 1_
- $a Mendenhall, William M $u Department of Radiation Oncology, University of Florida, Gainesville, FL, USA.
- 700 1_
- $a Eloy, Jean Anderson $u Department of Otolaryngology - Head and Neck Surgery, Neurological Institute of New Jersey, Rutgers New Jersey Medical School, Newark, NJ, USA.
- 700 1_
- $a Bishop, Justin A $u Departments of Pathology and Otolaryngology-Head and Neck Surgery, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
- 700 1_
- $a Devaney, Kenneth O $u Department of Pathology, Allegiance Health, Jackson, MI, USA.
- 700 1_
- $a Thompson, Lester D R $u Consultant Pathologist, Southern California Permanente Medical Group, Woodland Hills, CA, USA.
- 700 1_
- $a Hamoir, Marc $u Department of Head and Neck Surgery, Head and Neck Oncology Program, St Luc University Hospital and King Albert II Cancer Institute, Brussels, Belgium.
- 700 1_
- $a Slootweg, Pieter J $u Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
- 700 1_
- $a Vander Poorten, Vincent $u European Salivary Gland Society, Geneva, Switzerland; Otorhinolaryngology-Head and Neck Surgery, University Hospitals Leuven and KU Leuven, Department of Oncology, Section Head and Neck Oncology, Leuven, Belgium.
- 700 1_
- $a Williams, Michelle D $u Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- 700 1_
- $a Wenig, Bruce M $u Department of Pathology, Beth Israel Medical Center, New York, NY, USA.
- 700 1_
- $a Skálová, Alena $u Department of Pathology, Charles University in Prague, Faculty of Medicine in Plzen, Plzen, Czech Republic.
- 700 1_
- $a Ferlito, Alfio $u Coordinator of the International Head and Neck Scientific Group. Electronic address: a.ferlito@uniud.it.
- 773 0_
- $w MED00166565 $t Auris, nasus, larynx $x 1879-1476 $g Roč. 43, č. 5 (2016), s. 477-84
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27017314 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170427120654 $b ABA008
- 999 __
- $a ok $b bmc $g 1200456 $s 974769
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 43 $c 5 $d 477-84 $e 20160324 $i 1879-1476 $m Auris, nasus, larynx $n Auris Nasus Larynx $x MED00166565
- LZP __
- $a Pubmed-20170413
